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Polycystin-L (PCL), homologous to polycystin-2 (71% similarity in protein sequence), is the third member of the polycystin family of proteins.
Polycystin-1 and -2 are mutated in autosomal dominant polycystic kidney disease, but the physiological role of PCL has not been determined.
PCL acts as a Ca-regulated non-selective cation channel permeable to mono- and divalent cations. To further understand the biophysical and
pharmacological properties of PCL, we examined a series of organic cations for permeation and inhibition, using single-channel patch clamp and
whole-cell two-microelectrode voltage clamp techniques in conjunction with Xenopus oocyte expression. We found that PCL is permeable to
organic amines, methlyamine (MA, 3.8 Å), dimethylamine (DMA, 4.6 Å) and triethylamine (TriEA, 6 Å), and to tetra-alkylammonium cation
(TAA) tetra-methylammonium (TMA, 5.5–6.4 Å). TAA compounds tetra-ethylammonium (TEA, 6.1–8.2 Å) and tetra-propylammonium (TPA,
9.8 Å) were impermeable through PCL and exhibited weak inhibition on PCL (IC50 values>13 mM). Larger TAA cations tetra-butylammonium
(TBA, 11.6 Å) and tetra-pentylammonium (TPeA, 13.2 Å) were impermeable through PCL as well and showed strong inhibition (IC50 values of
2.7 mM and 1.3 μM, respectively). Inhibition by TBA was on decreasing the single-channel current amplitude and exhibited no effect on open
probability (NPo) or mean open time (MOT), suggesting that it blocks the PCL permeation pathway. In contract, TEA, TPA and TPeA reduced
NPo and MOT values but had no effect on the amplitude, suggesting their binding to a different site in PCL, which affects the channel gating.
Taken together, our studies revealed that PCL is permeable to organic amines and TAA cation TMA, and that inhibition of PCL by large TAA
cations exhibits two different mechanisms, presumably through binding either to the pore pathway to reduce permeant flux or to another site to
regulate the channel gating. These data allow to estimate a channel pore size of ∼7 Å for PCL.
© 2006 Elsevier B.V. All rights reserved.Keywords: Patch clamp; Voltage clamp; Xenopus oocyte; Polycystic kidney disease; Pore size; Organic amine; Tetra-alkylammonium1. Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is
an inherited nephropathy, primarily characterized by the
formation of fluid-filled cysts in the kidneys. It is one of the
most frequent genetic disorders affecting approximately 0.1%
of individuals and accounting for up to 10% of end-stage renal
failure. ADPKD also exhibits extrarenal manifestations, such as
hepatic and pancreatic cystogenesis, intracranial aneurysms and
cardiac mitral valve prolapse, and is often associated with
hypertension. PKD1 and PKD2, encoding polycystin-1 (PC1)
and -2 (PC2), respectively, are the two known genes responsible⁎ Corresponding author. Tel.: +1 780 492 2294; fax: +1 780 492 8915.
E-mail address: xzchen@ualberta.ca (X.-Z. Chen).
0005-2736/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2006.01.020for about 95% of ADPKD and have been mapped to
chromosomes 16p13.3 and 4q21–23, respectively [26]. Poly-
cystin-L (PCL), encoded by PKDL, is the third member of the
polycystin family [16]. As members of the transient receptor
potential (TRP) channels superfamily, PC1, PC2 and PCL have
also been called TRPP1, TRPP2 and TRPP3 (TRP-polycystin),
respectively [7]. PC1 is a large receptor-like integral membrane
protein involved in cell–cell and cell–matrix interactions.
PCL and PC2 are highly homologous (71% similarity) but
PCL seems not to be directly linked to ADPKD renal cyst
formation. However, the mouse orthologue of PCL is deleted in
krd (kidney and retinal defects) mice, resulting in defects in
kidney and retina [10,16]. PCL may be one of the candidates
linked to unmapped human genetic cystic disorders such as
dominantly transmitted glomerulocystic kidney disease of post-
infantile onset, isolated polycystic liver disease, and Hajdu–
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present in multiple tissues, including brain, retina, kidney, heart,
testis, liver, pancreas and spleen. In adult kidney, PCL is
predominantly localized in the apical region of the principal
cells of inner medullary collecting ducts [3]. In embryonic
kidney, it is found in the apical membrane of tubular epithelial
cells. PCL shares similar membrane topology and modest
sequence homology with TRP channels and the α-subunits of
voltage-gated K, Na and Ca channels. For example, it comprises
six transmembrane-spanning domains with both the carboxyl-
and amino-termini intracellularly localized. Indeed, recent
studies have demonstrated that PCL is a Ca-activated, Ca-
permeable, non-selective cation channel [6,14]. It is still
unknown how many subunits make up the pore of the PCL
channel. PCL channel possesses an EF-hand calcium-binding
motif in its C-terminus, suggesting a possible involvement of
intracellular calcium in its function. It was reported that EF-
hand serves to control (reduce) calcium-induced PCL channel
activation [13]. PCL associates with troponin I which inhibits
PCL channel activity [12].
Monovalent cations such as organic amines and tetra-
alkylammonium (TAA) compounds have been employed to
determine the pore diameters of ion channels. Methylamine
(MA) is an endogenous compound that is increased during liver
and renal failure, Alzheimer's disease, vascular dementia andFig. 1. Permeation of organic amines and TMA. Cell-attached mode of single-channel
the presence of 123 mM pipette K, Cs, MA, DMA, TriEA or TMA. Shown trace
relationships for various cations. (C) Single-channel conductance as a function of cati
Dashed line represents the arithmetic average of the inward currents generated by 1diabetes. It alters some neurobehavioral functions, probably by
acting as a potassium channel blocker [19]. Dimethylamine
(DMA) was used to investigate the pore size of PC2 channel
and ryanodine receptor [2,24]. Triethylamine (TriEA), tetra-
methylammonium (TMA), tetra-ethylammonium (TEA), tetra-
propylammonium (TPA), tetra-butylammonium (TBA) and
tetra-pentylammonium (TPeA) are known to block ion
permeation through K, Na and Cl channels, anthrax toxin
channels, ryanodine and NMDA receptors [18,20,28]. They
were also used to probe the structure of the internal and external
vestibules of K channel pores [8,15,28] and the pore sizes of
ryanodine receptor, K channel KcsA, NMDA receptor, PC2,
and vanilloid receptor (TRPV6) [1,2,9,22,27]. Using TAA
cations as permeant ions or inhibitors, the pore diameter of the
PC2 channel was recently estimated to be at least 11 Å [2].
Previous reports revealed that ryanodine receptor has a
minimum pore diameter of ∼7 Å and that the NMDA channel
pore size of ∼11 Å. TRPV6, which belongs to the family of
TRP channels, has a pore diameter of ∼5.4 Å. These TAA
compounds are also blockers of Na channels with affinities
positively correlated to the length of alkyl side chains [18]. In
the present study, we explored biophysical and pharmacological
properties of the PCL channel through examining the
permeation of and inhibition by monovalent organic amines
and TAA cations.patch clamp was performed. (A) Downward deflections recorded at −120 mV in
s were filtered at 200 Hz. The dashed lines indicate the closed state. (B) I–V
on diameter. (D) I–V curves obtained at molar fractions of K and TMA (in mM).
23 mM K and TMA.
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2.1. Oocyte preparation
Capped synthetic human PCL mRNA was synthesized by in vitro
transcription from a linearized template inserted in the pTLN2 vector, using
the mMESSAGE mMACHINE1 Kit (Ambion, Austin, TX, USA). Stage V-VI
oocytes were extracted from Xenopus laevis and defolliculated by collagenase
type I (2.5 mg/mL) (Sigma-Aldrich Canada, Oakville, ON, Canada) in the
Barth's solution (in mM: 88 NaCl, 1 KCl, 0.33 Ca(NO3)2, 0.41 CaCl2, 0.82
MgSO4, 2.4 NaHCO3, 10 HEPES, and pH 7.5) at room temperature (21–23 °C)
for 2 h. Oocytes were injected with 50 nl of water containing 20 or 40 ng of each
RNA 3–24 h following defolliculation. An equal volume of RNAase-free water
was injected into each control oocyte. Injected oocytes were incubated at 16–18
°C in the Barth's solution supplemented with antibiotics for 3–4 days prior to
experiments.
2.2. Two-electrode voltage clamp
Two-electrode voltage clamp was performed as described previously [14].
Briefly, the two electrodes (Capillary pipettes, Warner Instruments, Hamden,
CT, USA) impaling Xenopus oocytes were filled with 3 M KCl to form a tip
resistance of 0.3–2 MΩ. Oocyte whole-cell currents were recorded using a
Geneclamp 500B amplifier and a Digidata 1322A AD/DA converter (Axon
Instruments, Union City, CA, USA). In experiments using a ramp protocol,
currents and voltages were sampled at internals of 200 μs and filtered at 2 kHz
using an 8 pole Bessel filter. In experiments using a gap-free protocol, current/
voltage signals were sampled at intervals of 200 ms. The modified Choline-Cl-
containing solution contained (in mM): 100 Choline-Cl, 2 KCl, 0.2 MgCl2, 10
HEPES, pH 7.5.Fig. 2. Permeation of and inhibition by TAA cations TEA, TPA, TBA and TPeA. (A)
TPeA in the pipette at +100 or −120 mV. (B) Averaged I–V relationships for K, TE2.3. Single-channel patch clamp
Vitelline membranes of oocytes were removed manually following
incubation of the oocytes at room temperature in a hypertonic solution
containing (in mM): 220 NaCl, 50 sucrose, 1 EGTA, 1 MgCl2, 10 HEPES, pH
7.5. Oocytes were then transferred to the Barth's solution and allowed to recover
for 10–20 min before patch clamping. Electrodes were filled with a pipette
solution containing 123 mM K (in mM: 110 KCl, 13 KOH, 10 HEPES, and pH
7.4) to form a tip resistance of 3–6 MΩ. The Barth's solution was used in the
bath. Single channel currents were recorded in cell-attached configuration using
PC-ONE Patch Clamp amplifier (Dagan Corp., Minneapolis, MN, USA),
DigiData 1322A interface, and Clampex 9 software (Axon Instruments).
Recordings started after seal resistance reached at least 3–5 GΩ. Current/voltage
signals were sampled every 200 μs and filtered at 2 kHz. All chemicals were
purchased from Sigma-Aldrich Canada.
2.4. Statistics and data analysis
Data obtained from the two-microelectrode voltage-clamp and patch-clamp
experiments were analyzed using Clampfit 9. Single-channel conductance
values were obtained from Gaussian fits to All-Point Histograms. The open
probability times the number of channels in the patch (NPo, designated ‘open
probability’ hereafter) and channel mean open time (MOT) values were obtained
from currents generated either by voltage pulses of 10 s per pulse or by gap-free
recordings of 10 s long. For the MOT analysis, recordings with single openings
were used and filtered at 500 Hz (Gaussian). Analyzed data were plotted using
Sigmaplot 9 (Jandel Scientific Software, San Rafael, CA, USA) and expressed
in the form of mean±SE (N), where SE represents the standard error of the mean
and N indicates the number of oocytes (or oocyte patches) tested. Curve fitting
and data filtering were performed using Clampfit 9 or Sigmaplot 9. Dose–Representative traces recorded in the presence of 123 mMK, TEA, TPA, TBA or
A and TPA (N=12) obtained under the same conditions as in panel A.
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([S]/IC50)
p}, where [S] represents the concentration of an inhibitor and p is the
power (or Hill coefficient). Comparison between two sets of data was analyzed
by t-test or two-way ANOVA, and a probability value (P) of less than 0.05
(or 0.01) was considered significant (or very significant).3. Results
To gain more insights into biophysical and pharmacological
properties of PCL we tested a series of organic amines and
TAA cations with varying ionic diameters for their permeabil-
ity through and inhibition of PCL channel expressed in
Xenopus oocytes. PCL is a large conductance cation channel of
366 pS in the presence of 123 mM K [14]. Using the cell-
attached mode of single-channel patch clamp, we found that
MA (3.8 Å), DMA (4.6 Å), TriEA (6 Å) and TMA (5.5–6.4 Å)
were permeable through PCL channel with current amplitudes
dependent on cation size (Fig. 1A and B). In fact, single-
channel conductance inversely correlated with cation size
(Fig. 1C). As expected, the outward single-channel currentFig. 3. Effects of TEA on PCL. (A) Representative single-channel recordings obtain
single oocyte voltage clamped at −50 mV. “Choline” indicates the solution containing
mMCaCl2. The dashed lines represent 10-min periods during which the oocyte was no
of 20 mM TEA (N=10). (D) Effects of 20 mM TEA (N=10), 20 mM TPA (N=11)amplitudes at positive voltages (+Vm, +20 to +120 mV),
presumably elicited by endogenous permeant cations inside
oocytes, mainly K, were not significantly different, in the
presence of extracellular 123 mM K, Cs, MA, DMA, TriEA
or TMA (Fig. 1B).
Single channel conductance can depend on the mole fraction
of two permeant ions in a peculiar way, such that the
conductance is smaller than the one calculated based on mole
fraction (anomalous mole-fraction behavior). To test whether
PCL channel exhibits anomalous mole-fraction dependence, we
measured the inward currents through PCL channel in the
presence of K and TMA (61.5 mM each). We found that the
resulting amplitudes were smaller than the arithmetic average of
those obtained in the presence of 123 mM K and TMA alone
(Fig. 1D). This result indicates that the two permeant cations
exhibit interaction between them when passing through PCL
channel.
We next tested the permeation of larger TAA cations
through the PCL channel. In the presence of 123 mM TEA
(6.1–8.2 Å) or TPA (9.8 Å) in the pipette, channel openingsed with or without TEA (20 mM). (B) Representative whole-cell recording in a
(in mM): 100 Choline-Cl, 2 KCl, 0.2 MgCl2, 10 HEPES, pH 7.5, and “Ca” = 5
t voltage clamped. (C) Averaged whole-cell I–V curves before and after addition
, and 1 μM TPeA (N=14) on NPo and MOT at −Vm and +Vm.
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(−180 to −20 mV) (Fig. 2A and B). This indicates that TEA
and TPA were impermeable through PCL. There was no
difference in the single-channel amplitudes of the PCL
channel +Vm, whether the pipette contained 123 mM K,
TEA or TPA (Fig. 2B, N=12). In contrast, in the presence of
123 mM TBA (11.6 Å) or TPeA (13.2 Å) in the pipette, at
voltages between −180 and +180 mV, no channel openings
were observed, indicating that these two cations are
impermeable through PCL as well and inhibit outward
currents associated with effluxes of oocytes endogenous
permeant cations through PCL.
We next examined inhibition of K currents by TEA, TPA,
TBA and TPeA, using both single-channel patch clamp and
whole-cell voltage clamp. Addition of TEA at 20 mM to the
pipette containing 123 mM K reduced the NPo and MOT values
of inward and outward single-channel currents (Fig. 3A). In
average, NPo decreased from 0.35±0.04 (N=40) and 0.16±0.02
(N=35), in the absence of TEA, to 0.25±0.03 (N=15, P<0.05)
and 0.11±0.02 (N=12, P<0.05), in the presence of pipette TEA
(20 mM), at −Vm, and +Vm, respectively (Fig. 3D). Under the
same condition, MOT decreased from 65±4 (N=40) and 19±2
ms (N=35) to 46±5 (N=15) and 15±2 ms (N=12) at −Vm and
+Vm, respectively. In contrast, TEA did not exhibit significant
effect on the outward single-channel current amplitude.
Inhibitory effect of TEA was also observed with whole-cell
recordings (Fig. 3B and C). Inward currents at −50 mV in the
presence of 100 mM Choline and 5 mM Ca decreased 44±7%
(N=8) by 20 mM TEA, with an IC50 value of 23±3 mM
(N=31).Fig. 4. Effects of TEA on PCL. (A) Representative single-channel recordings obtain
single oocyte voltage clamped at −50 mV. (C) Averaged whole-cell I–V curves befoTPA exhibited similar characteristics as TEA (Fig. 4A–C).
TPA at 20 mM inhibited the single-channel activities of the PCL
channel (Fig. 4A). In average, NPo decreased to 0.14±0.02
(N=12, P<0.01) and 0.08±0.01 (N=11, P<0.01) at −Vm and
+Vm, respectively (Fig. 3D). MOT decreased to 41±4 ms
(N=12) and 12±1 ms (N=11), respectively. Like TEA, TPA
had no effect on the current amplitude. Inhibitory effect of TPA
was also supported by whole-cell data (Fig. 4B and C). Inward
currents at −50 mV in the presence of 100 mM Choline and 5
mM Ca decreased 68±7% (N=9) by 20 mM TPA (Fig. 4B),
with an IC50 value of 13±2 mM (N=29).
In contrast to TEA and TPA, TBA exhibited inhibition of
the PCL single-channel amplitude at the whole voltage range
tested and had no effects on NPo and MOT (Fig. 5A). The
concentration dependence of the inhibition was represented by
averaged current–voltage (I–V) curves obtained in the
presence 0.1, 1, 10, 33 mM TBA in the pipette (Fig. 5B).
For example, at −120 mV, the presence of 0.1, 1, 10 and 33
mM TBA in the pipette containing 123 mM K significantly
reduced channel inward-current amplitude to 95±11%
(P>0.05, N=7), 75±9% (P<0.05, N=10), 46±3% (P<0.01,
N=15) and 25±4% (P<0.01, N=8), respectively. The IC50
values decreased with hyperpolarization, from 16.2 mM at −40
mV to 6.8 mM at −120 mV, suggesting voltage-dependent
inhibition by TBA (Fig. 5C). TBA inhibition was also
demonstrated at the whole-cell level (Fig. 5D and E). Inward
currents at −50 mV activated by 5 mM Ca were reduced to
18% by 10 mM TBA (Fig. 5D).
TPeA is the largest cation tested in the current study. TPeA
did not permeate PCL (Fig. 2A) but acted as a high-affinityed with or without TPA (20 mM). (B) Representative whole-cell recording in a
re and after addition of 20 mM TPA (N=11).
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solution PCL channel activity was almost abolished at both
+Vm and −Vm. TPeA reduced NPo and MOT, but not the
single-channel conductance (Figs. 3D and 6A). The inhibition
by TPeA was concentration-dependent, and TPeA at 10 μM
completely abolished PCL channel opening (Fig. 6B). The
IC50 values for TPeA on NPo were 1.2±0.1 μM at +Vm and
0.60±0.02 μM at −Vm (Fig. 6B, left). The IC50 values for
TPeA on MOT were 0.54±0.16 μM at +Vm and 0.72±0.17
μM at −Vm (Fig. 6B, right). TPeA also exhibited potent
inhibition of PCL whole-cell currents (Fig. 7A and B), with
an IC50 value of 1.3±0.1 μM (N=15) at −50 mV, much
smaller than that for TBA (2.7±0.2 mM, N=10), TPA
(13±1.2 mM, N=11) and TEA (23±3 mM, N=13) (Fig. 7C).
Thus, TPeA is the most potent inhibitor tested when
compared with the three other inhibitors and the inhibitionFig. 5. Inhibition of PCL by TBA. (A) Representative tracings obtained in the presenc
(B) Averaged I–V relationships (N=25) obtained at various TBA concentrations. (C)
panel B. (D) Representative whole-cell recording in a single oocyte voltage clamped
before and after addition of 10 mM TBA (N=8).potency of these TAA compounds inversely correlated with
their size (Fig. 7D).
4. Discussion
In the present study we investigated the permeation and
inhibition of the PCL channel by monovalent organic amines
and TAA cations of various sizes, including MA, DMA,
TriEA, TMA, TEA, TPA, TBA and TPeA, using the whole-
cell two-microelectrode voltage clamp and single-channel
patch clamp. The PCL single-channel conductance decreased
as the size of cations increased (Fig. 1). Similar conclusion
was previously drawn for ryanodine receptor [23]. TEA, TPA,
TBA and TPeA are not permeable through PCL and inhibited
whole-cell Ca-induced activated currents and basal single-
channel activities of PCL. Inhibition potency correlatese of 0 (Control), 10 or 33 mM TBA at various membrane potentials as indicated.
Voltage dependence of IC50 for TBA inhibition obtained from the data shown in
at −50 mV with or without 10 mM TBA. (E) Averaged whole-cell I–V curves
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NPo and MOT with low potency, while the inhibition by
TPeA was at least three magnitudes more potent. These three
inhibitors did not significantly affect single-channel amplitude,
suggesting that they bind a site away from the PCL pore
pathway. In contrast, TBA reduced single-channel current
amplitudes of PCL but did not reduce NPo and MOT,
suggesting binding to a site at the pore entry, which indicates
that PCL may possess an extracellular vestibule of about 12 Å
in size.
Monovalent inorganic and organic cations have been used as
biophysical probes for delineating the pore and vestibule of ion
channels. The largest tested cations permeable through PCL
were TriEA and TMA and smallest tested cation impermeable
through PCL was TEA. The sizes of TriEA, TMA and TEA are
in the range of 6–7.2 Å [2,23], 5.5–6.4 Å [11,25] and 6.1–8.2 Å
[2], respectively. Thus the PCL pore size can be estimated to be
∼7 Å, which is comparable with TRPV6 (∼5.4 Å), L-type
voltage-gated Ca channel (6.2 Å)[5] and ryanodine receptor (∼7
Å) [1,27].
Interestingly, although PCL and PC2 are highly homolo-
gous and PC2 has smaller single-channel conductance thanFig. 6. Effects of TPeA on PCL single-channel currents. (A) Representative recording
(B) Concentration-dependent effects of TPeA on NPo (left panel) and MOT (right pPCL, the pore size of PC2 was recently estimated to be at least
11 Å as it is permeable to TPeA [2]. This suggests that other
differences in the pore geometry of these two homologous
channels, e.g., in selectivity filter and pore depth, may affect
cation permeation.
TAA compounds are well-known inhibitors of K channels
[17]. TEA and larger TAA compounds, such as TBA and
TPeA, are known to block ion permeation through ryanodine
receptor, neuronal chloride and anthrax toxin channels
[1,4,21]. Using energy-minimized molecular models of
TAA cations and independent molecular dynamics analysis,
it was found that the diameter of these molecules increased
by ∼2 Å per symmetrical addition of a methylene group:
TMA has one carbon alkyl side chain with a size of 5.5–6.4
Å; TEA, 2 side chains, 6.1–8.2 Å; TPA, 3 side chains, 9.8
Å; TBA, 4 side chains, 11.6 Å; and TPeA, 5 side chains,
13.2 Å [17,24]. In fact, an increase in the molecular diameter
of TAA cations due to addition of carbon alkyl side chains is
accompanied by a proportional increase in their hydropho-
bicity. Whether/how the hydrophobicity of these TAA cations
influences their potency of inhibition remains to be
investigated.s in the presence or absence of 1 μM TPeA in the pipette containing 123 mM K.
anel) at +Vm or −Vm. Shown data were averaged from 20 measurements.
Fig. 7. Inhibition of PCL whole-cell currents by TPeA. (A) Representative whole-cell current recording from an oocyte showing the inhibition of PCL channel
activation by TPeA. Currents carried by Ca were measured at −50 mV. (B) Averaged I–V relationships (N=13) for PCL channels in the presence or absence of 1 μM
TPeA. (C) Concentration-dependent inhibition of PCL whole-cell current by the four TAA cations. Each point was averaged from 10 determinations. (D) IC50 values
for TAA cations inhibition as a function of their molecular sizes.
204 X.-Q. Dai et al. / Biochimica et Biophysica Acta 1758 (2006) 197–205In summary, we discovered novel biophysical and pharma-
cological properties of the PCL channel through examining the
permeation of and inhibition by monovalent organic amines and
TAA cations.
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